Total glycosylated haemoglobin (HbA1) levels from capillary blood were studied retrospectively during a 1-year period in 148 diabetic children aged between 1.9 and 16.8 years. The clinic range for HbA1 was 6.7 to 22.2% and the results were normally distributed (mean +/- SD 13.2 +/- 2.8%). The normal range in non-diabetics using this method is 4.9 to 8.0%. Results from children who had had diabetes for more than 5 years were higher than those from children with diabetes of 2 to 5 years' duration. Girls had higher average values during the 1-year period than boys. HbA1 measurement serves to identify the deficiencies of current diabetic treatment regimens. It also has more immediate practical benefits in focusing attention on children whose control is deteriorating.
Control of juvenile diabetes mellitus and its relationship to endogenous insulin secretion as measured by C-peptide immunoreactivity
The relationship between blood glycosylated haemoglobin and home capillary blood glucose levels in diabetics
Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes
Human insulin and porcine insulin in the treatment of diabetic children: comparison of metabolic control and insulin antibody production
Systematic review of communication technologies to promote access and engagement of young people with diabetes into healthcare
Monitoring glucose control and use of a diabetes control index in insulin-dependent diabetes mellitus
Adolescents' and their parents' views on the acceptability and design of a new diabetes education programme: a focus group analysis
Understanding adolescent type 1 diabetes self-management as an adaptive process: A grounded theory approach
Clinical and psychological course of diabetes from adolescence to young adulthood: a longitudinal cohort study
A novel capillary collection method for obtaining current glycosylated haemoglobin levels in diabetic children
The feasibility of a potentially 'ideal' system of integrated diabetes care and education based on a day centre
District Diabetes Centres in the United Kingdom. A report on a workshop held by the Diabetes Education Study group on behalf of the British Diabetic Association
Does recombinant human insulin-like growth factor I have a role in the treatment of type I (insulin dependent) diabetes during puberty?
Autoimmune Diabetes & Tolerance
Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.